Join us for a comprehensive presentation that explores strategic evaluation techniques for both medical devices and pharmaceuticals within the diagnostic imaging space. This session will guide participants through essential evaluation criteria such as demonstrated quality, supply chain reliability, competitive pricing, and clinical efficacy. A special focus will be placed on conducting a straightforward risk-benefit analysis. Using vascular injector syringes as a case study, the presentation will also introduce a financial assessment tool to aid in making economically sound decisions by evaluating costs and benefits. This approach aims to equip healthcare decision-makers with the tools necessary for optimizing both patient outcomes and operational efficiency.

Curated content from the AHRA 2024 Annual Meeting, CLIMB 2024, and live webinars. FREE for AHRA Members! Sponsored by Bayer.

This dynamic session is for individuals responsible for any portion of the charge capture, coding, documentation, billing, and account follow-up of radiology services. All the 2025 radiology coding updates will be reviewed in detail as well as other key items of concern related to imaging services, including but not limited to, new telemedicine visit codes, MR safety codes, supervision, reimbursement, and audit concerns. Radiology administrators as well as professionals involved in radiology compliance and revenue cycle will gain the information that they need to ensure correct coding and compliance for their organizations. It is recommended that appropriate individuals from Compliance and Finance be invited to ensure consistency and accuracy within the entire organization.

AHRA January/February 2025 Quick Credit - The credit earned from the Quick Credit test accompanying this article may be applied to the AHRA operations management (OM) domain.

AHRA January/February 2025 Quick Credit - ​The credit earned from the Quick Credit test accompanying this article may be applied to the AHRA operations management (OM) or communications and information management (CI) domains

The presentation will cover the features and uses of two different Bracco products that each provide unique value to their areas of imaging. Vueway® (gadopiclenol) is the first true high-relaxivity macrocyclic GBCA approved for use in the U.S., at a low Gd dose of 0.05 mmol/kg. Varibar® (barium sulfate 40% w/v) is a suite of 5 related barium preparations specifically designed and approved for use in the modified barium swallow (MBS) examination – the only such barium products available. Varibar was used in the clinical validation of the standardized Modified Barium Swallow Impairment Profile (MBSImP™©) protocol for evaluating swallowing disorders in adults.

AHRA November/December 2024 Quick Credit The credit earned from the Quick Credit test accompanying this article may be applied to the AHRA Operations Management (OM) and Asset Resource Management domain.

AHRA November/December 2024 Quick Credit The credit earned from the Quick Credit test accompanying this article may be applied to the AHRA Operations Management (OM) and Fiscal Management (FM) domain.

Join us for an informative webinar that delves into the upcoming CMS Radiation Dose Quality Measures including the new Merit-based Incentive Payment System (MIPS) measure and Inpatient Quality Reports (IQR) beginning in 2025. This session will provide a comprehensive overview of the new measures and the essential steps needed to ensure that institutions are well-prepared for these changes and how to prepare for reporting. We will also discuss how Alara and Bayer’s Radimetrics® Dose Management System can be deployed to facilitate compliance with the new eCQMs.

In 2025, the Centers for Medicare and Medicaid Services (CMS) will introduce new reporting requirements that will directly impact reimbursement for healthcare organizations. This educational webinar, hosted by Olav Christianson—author of foundational papers for CMS measure—will guide attendees through the complexities of these new requirements. The session will provide a clear, educational breakdown of the CMS reporting framework, exploring timelines, data elements, and the measure's calculation. Attendees will leave with a firm understanding of how to approach compliance without being overwhelmed by technicalities. This is a non-promotional, content-rich session designed to educate rather than promote specific solutions.